April 22, 2024

Bio-Europe 2025

Bio-Europe 2025

Europe’s premier partnering event

November 3–5, 2025 | Vienna, Austria

November 11–12, 2025 | Digital Partnering

BIO-Europe will host over 29,000 one-to-one meetings. The powerful partneringONE platform allows you to effortlessly and efficiently search for your most ideal partners. BIO-Europe will feature a distinguished lineup of speakers, including leading experts and visionaries from the biotech and pharma industries, who will take you on a journey of the past 30 years of experiences, partnerships and innovation and envision trends in the next 30 years to come.


BioRN Members get a 15 %  discount.

Registration Rates

EARLY BIRD:
by July 25
by Sept. 12 by Oct. 17 by Nov. 1 on-site DIGITAL PASS w/o on-site access
R&D Company, Investor, Government €       2.695,00  €        2.895,00  €   3.195,00  €   3.495,00  €   3.795,00  €        1.695,00
Biotech & Academics Pre-Revenue Offer TWO registrations for the price of ONE. Deadline to apply: Oct. 27
Service Provider  €       3.395,00  €        3.595,00  €   4.295,00  €   4.595,00  €   4.895,00  €        2.695,00
Young Innovator Rate €           795,00  €            995,00  €   1.195,00  €   1.195,00  €   3.795,00

Please contact Nicole Hecht (nh(at)biorn.org) for the Discount Code and more Information.

Important: Those companies that have booked a stand participation via the German Pavilion will continue to receive their tickets at the lower R&D / Investor / Government rate. Registration information will be shared directly by the organizing company at a later date.


Please visit the German Pavilion @ BioEurope Fall 2025 in Vienna

Germany@BioEurope Wien 2025

register now

Our latest News

discover more
Universität Heidelberg with 16 “Highly Cited Researchers”

Universität Heidelberg with 16 “Highly Cited Researchers”

International evaluation names researchers whose publications have been most cited worldwide 16 researchers from Heidelberg University feature on the recently published list of “Highly Cited Researchers”. This international evaluation names researchers whose publications have been cited most frequently worldwide in their respective field or who have an outstanding track-record of publications across several disciplines. The […]

Universität Heidelberg: New DFG Research Unit in Oncology

Universität Heidelberg: New DFG Research Unit in Oncology

GenoMiCC consortium deals with functional genomics and microbiomics in colorectal cancer and is coordinated at the Medical Faculty Mannheim In the latest approval round of the German Research Foundation (DFG), Heidelberg University has been successful with a grant application for a new Research Unit in oncology. The GenoMiCC consortium pursues the goal of identifying new […]

Merck and Promega collaborate on 3D cell technology for drug discovery

Merck and Promega collaborate on 3D cell technology for drug discovery

Full text in German below. Merck und Promega arbeiten gemeinsam an 3D-Zelltechnologie für die Wirkstoffforschung Strategische Partnerschaft bündelt Know-how von Merck im Bereich Organoide mit Promegas Assay-TechnologienForschende erhalten besseren und schnelleren Zugang zu krankheitsrelevanten ZellmodellenStärkt Mercks Position bei zukunftsweisenden Tools und Lösungen auf dem Gebiet der Biologie Darmstadt, Deutschland. (06. November 2025) Merck, ein führendes Wissenschafts- […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp